Lupin receives USFDA approval for generic drug to treat sleep disorders

Short resume:

received
90%
sleep
90%
disorder
80%
launch
80%
Lupin receives USFDA approval for generic drug to treat sleep disorders

NEW DELHI: Lupin Pharmaceuticals (LPI), US subsidiary of Indian drug maker Lupin, has received the US Food and Drug Administration’s (FDA) approval for its Armodafinil tablets indicated to improve wakefulness in adult patients with obstructive sleep …
Source Economic Times
Read More…

More News


Be the first to comment

Leave a Reply

Your email address will not be published.


*